Role of estrogen receptor α transcriptional coregulators in tamoxifen resistance in breast cancer
- 20 July 2006
- journal article
- review article
- Published by Elsevier BV in Maturitas
- Vol. 54 (4), 342-351
- https://doi.org/10.1016/j.maturitas.2006.06.003
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1α/CXCL12Carcinogenesis: Integrative Cancer Research, 2005
- XBP-1 increases ERα transcriptional activity through regulation of large-scale chromatin unfoldingBiochemical and Biophysical Research Communications, 2004
- DNMT3B interacts with hSNF2H chromatin remodeling enzyme, HDACs 1 and 2, and components of the histone methylation systemBiochemical and Biophysical Research Communications, 2004
- ERBP, a novel estrogen receptor binding protein enhancing the activity of estrogen receptorBiochemical and Biophysical Research Communications, 2004
- Antiestrogen resistance in breast cancer and the role of estrogen receptor signalingOncogene, 2003
- A Negative Coregulator for the Human ERMolecular Endocrinology, 2002
- Endocrine-responsive breast cancer and strategies for combating resistanceNature Reviews Cancer, 2002
- Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated TranscriptionCell, 2000
- AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian CancerScience, 1997
- Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor SuperfamilyScience, 1995